28 studies found for:    "X-linked ichthyosis"
Show Display Options
Rank Status Study
1 Recruiting A Phase 1 Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Solid Tumors
Conditions: Bladder Cancer;   Lung Cancer;   Small Cell Lung Cancer;   Small-cell Lung Cancer;   SCLC;   Soft-tissue Sarcoma;   Sarcoma;   STS;   Breast Cancer;   Triple Negative Breast Cancer;   Triple-negative Breast Cancer;   TNBC;   Human Papilloma Virus-positive Anogenital Cancer;   HPV-positive Anogenital Cancer;   Anal Cancer;   Cervical Cancer;   Vaginal Cancer
Interventions: Biological: MEDI4736;   Biological: tremelimumab
2 Recruiting STS/ACC Transcatheter Valve Therapy Registry (TVT Registry)
Condition: Aortic Valve Stenosis
Intervention: Procedure: Transcatheter Aortic Valve Replacement
3 Unknown  Contribution of F18-FDG PET/CT to the Early Assessment of Pazopanib Therapy Efficacy in Advanced Soft Tissue Sarcoma
Condition: Soft Tissue Sarcoma (STS)
Intervention: Other: F18-FGD PET/CT
4 Recruiting Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS)
Conditions: Sarcoma;   Leiomyosarcoma;   Malignant Peripheral Nerve Sheath Tumor;   Malignant Fibrous;   Histiocytoma/Undifferentiated Pleomorphic Sarcoma
Intervention: Drug: Gemcitabine and Docetaxel in Combination with Pazopanib
5 Completed Safety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS)
Conditions: Gastrointestinal Stromal Tumors;   Soft Tissue Sarcomas
Intervention: Drug: IPI-504
6 Recruiting Individualizing Pazopanib Therapy by exploRing the Role of Early Metabolic responsE and Drug Exposure as a preDICTor for Treatment Outcome in Patients With STS
Condition: Sarcoma, Soft Tissue
Intervention: Drug: Pazopanib
7 Recruiting STS/ACC TVT Registry Mitral Module
Condition: Mitral Valve Regurgitation
Intervention: Device: Leaflet Clip
8 Recruiting A Phase II Study of Anlotinib Hydrochloric Capsule in STS Patients
Condition: Cancer
Intervention: Drug: Anlotinib Hydrochloric Capsule
9 Completed Bendamustin Hydrochloride in Patients With Soft Tissue Sarcoma (STS)
Condition: Sarcoma, Soft Tissue
Intervention: Drug: Bendamustin
10 Active, not recruiting Trofosfamide Versus Adriamycin in Elderly Patients With Soft Tissue Sarcoma (STS)
Condition: Sarcoma, Soft Tissue
Interventions: Drug: Adriamycin;   Drug: Trofosfamide
11 Active, not recruiting
Has Results
Radiation Therapy and Intratumoral Autologous Dendritic Cells in Soft Tissue Sarcomas (STS)
Condition: Soft Tissue Sarcoma
Interventions: Procedure: External Beam Radiation Therapy (RT);   Biological: Autologous Dendritic Cells
12 Completed Neoadjuvant Adriamycin and Ifosfamide Plus High-Dose ICE in Patients With Soft Tissue Sarcoma (STS)
Condition: Sarcoma, Soft Tissue
Interventions: Drug: Adriamycin;   Drug: Ifosfamide;   Drug: Etoposide;   Drug: Carboplatin
13 Recruiting Study in Patients With Advanced Soft Tissue Sarcoma (STS) After Failure of Anthracyclines and/or Ifosfamide
Condition: Soft Tissue Sarcoma
Intervention:
14 Unknown  Study on Efficacy and Tolerability of Vorinostat in Patients With Advanced, Metastatic Soft Tissue Sarcoma (STS)
Condition: Soft Tissue Sarcoma
Intervention: Drug: Vorinostat
15 Withdrawn A Pilot Study to Evaluate Topical Sodium Thiosulfate Therapy for Calcinosis Cutis
Condition: Calcinosis Cutis
Interventions: Drug: Sodium thiosulfate;   Drug: Placebo
16 Completed Selegiline for Smoking Cessation - 1
Condition: Nicotine Dependence
Intervention: Drug: Selegiline
17 Completed Safety and Effectiveness of the Selegiline "Patch" for Decreased Mental Function in HIV Patients
Conditions: Cognition Disorders;   HIV Infections
Intervention: Drug: Selegiline hydrochloride
18 Recruiting Trabectedin First Line Therapy In Unfit Sarcoma Study
Conditions: Metastatic and Locally Advanced Soft Tissue Tumor Patients Unfit to Receive;   Standard Chemotherapy
Intervention: Drug: Trabectedin
19 Completed Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
Condition: Sarcoma
Intervention: Drug: soblidotin
20 Recruiting Phase II Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Soft Tissue Sarcomas.
Condition: Locally Advanced or Metastatic Soft Tissue Sarcoma
Interventions: Drug: NGR-hTNF;   Drug: Doxorubicin

   Previous Page Studies Shown (1-20) Next Page (21-28) Show next page of results    Last Page
Indicates status has not been verified in more than two years